Neurogen Corporation

(NASDAQ:NRGN)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Operating revenue
Total Revenue — — — —
Operating Revenue — — — —
Adjustments To Revenue — — — —
Cost Of Sales -70 -162 -563 -565
Cost Of Sales With Depreciation — — — —
Gross Operating Profit 70 162 563 565
Operating Expenses
Research And Development Expenses 6,277 7,995 12,054 12,774
Selling General And Administrative Expenses 1,987 756 2,163 2,498
Advertising Expenses — — — —
Operating Income Before Depreciation -8,194 -8,589 -13,654 -14,707
Operating Income -11,417 -18,591 -16,707 -15,272
Depreciation 70 162 563 565
Depreciation Unreconciled — — — —
Amortization — — — —
Amortization Of Intangibles — — — —
Operating Income After Depreciation -8,264 -8,751 -14,217 -15,272
Non Operating Expenses
Interest Expense 121 130 151 174
Pre Tax Income -6,550 -6,457 -16,541 -14,909
Income Taxes -23 -23 -23 -11
Minority Interest — — — —
Income Before Income Taxes -6,550 -6,457 -16,541 -14,909
Net Income From Continuing Operations -6,527 -6,434 -16,518 -14,898
Net Income From Discontinued Operations — — — —
Net Income From Total Operations -6,527 -6,434 -16,518 -14,898
Non Recurring Events
Extraordinary Income Losses — — — —
Income From Cummulated Effect Of Accounting Changes — — — —
Income From Tax Loss Carryforward — — — —
Other Gains And Losses — — — —
Total Net Income -6,527 -6,434 -16,518 -14,898
Normalized Income -3,374 3,406 -14,028 -14,898
NetIncome Available For Common -31,740 -11,841 -16,518 -14,898
Preferred Dividends 25,213 5,407 — —
Excise Taxes — — — —